Rivaroxaban 50228-0513
Product NDC
50228-0513- Manufacturer
- Sciegen Pharmaceuticals,inc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 4, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA218117
Need to source Rivaroxaban? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rivaroxaban | 2.5 mg/1 |
Drug Class
Factor Xa Inhibitor [EPC]Factor Xa Inhibitor [EPC]Factor Xa Inhibitors [MoA]
Packaging Options(2)
180 TABLET, FILM COATED in 1 BOTTLE (50228-513-18)
60 TABLET, FILM COATED in 1 BOTTLE (50228-513-60)